Approval · Notice of Compliance 25631 · 2021
MITOMYCIN FOR INJECTION: Notice of Compliance 25631
Issued April 9, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 25631
- Date
- April 9, 2021
- Company
- Teva Canada LimitedToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Transfer manufacturing site. rebrand product
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MITOMYCIN FOR INJECTION | Not yet assigned | — |
Medicinal ingredients
- MITOMYCIN 20 MG per VIAL